In some cases, results from large human trials are already in
To date, there have been no recorded incidences of coma or death arising from Melanotan use
Hosen MB, Islam MR, Begum F, Kabir Y, Howlader MZH
Other potential side effects may include constipation, diarrhea, or decreased appetite
GHK-Cu topical products are commonly discussed in concentration ranges from 2% to 10%
The study was sponsored by Eli Lilly and Company, the manufacturer of orforglipron and the injectable GLP-1, tirzepatide Side-effects were similar to other GLP-1s, including mild to moderate nausea, diarrhoea, constipation and bloating Its important to highlight that the study was quite small (just over 100 people in each arm of the study received active treatment), so more research is needed over a longer time period, says Dr Cork